Newsletter

Weekly Briefing Note for Founders

29th October 2026

This week on the startup to scaleup journey:
  • The grant that keeps your startup alive could be the one that sinks it

The grant that keeps your startup alive could be the one that sinks it

Ask a UK DeepTech founder how the company was first financed, and the answer will often begin with a grant. Long before the first institutional investment, there is an application to Innovate UK or the European Innovation Council. Winning one has become close to a rite of passage, and founders give it the time, care and hope they might otherwise reserve for a funding round. On the surface, it is the easiest money a startup will ever raise.

But most founders read the grant the wrong way. They treat it as cheap equity with a stamp of approval attached: money that dilutes no one, and the backing of a respected public body that should make the next investor easier to persuade. On both counts the evidence says otherwise. Investors pay for neither the cash nor the logo. They pay for the specific uncertainty the grant removes.

That uncertainty is the proof point: the one technical question the next round will be priced on. A grant aimed squarely at it is worth far more than its face value. A grant aimed anywhere else may buy time, but time is not what investors are waiting for.

This matters more for UK founders now than at any point in a decade. Innovate UK's Smart grants, the open door for any ambitious R&D project, are closed to new applications. The largest European alternative, the European Innovation Council's Accelerator, offers UK companies grants of up to €2.5m, but each company can receive only one under the current programme. Fewer shots means each one must land on the proof point.

The funder's approval is not what investors buy

The most rigorous evidence comes from studies that compare companies just above and just below a grant's funding cut-off, firms the assessors judged almost identical. Sabrina Howell's study of US energy startups found that an early grant roughly doubled the chance of later venture funding. But the effect did not come from the funder's approval. The grants worked because they funded technology prototyping.

A study of the EU's equivalent programme across Europe reached the same verdict. Companies that won the money outperformed. The programme also gave some applicants a Seal of Excellence: an official certificate that their project deserved funding, awarded when the budget ran out before it reached them. It is about as pure a test of the funder's approval as exists, and those companies did no better than applicants who received nothing.

That should change how founders talk about grants in a pitch. A grant tells an investor that a panel liked the plan. A working prototype tells them the plan works. The logo on slide twelve is not doing the work. What the money paid for is.

This is not to say an award never helps. Founders in Innovate UK's own evaluation still describe its credibility as valuable, and in individual cases it plainly opens doors. But across hundreds of companies, the endorsement on its own made no measurable difference. The proof does.

Investors pay for the proof point

An independent evaluation of 1,688 Smart grant projects, published by Innovate UK in July, found the grants increased later equity investment by 8 to 10 per cent against closely matched rejected applicants. Its case studies explain why. Investors often steered founders towards lower-risk work that protected their runway, and away from the riskier development that would de-risk the technology. The grant paid for exactly that work. One company used it to build a pilot plant producing battery-grade lithium carbonate and closed a £4.4m equity round on the results.

The companies that failed to raise afterwards tell the same story from the other side. Their grants had typically not taken the technology far enough. In one case, investors wanted a full-scale demonstrator the grant could never fund.

By the time the evaluation was carried out, 35 per cent of the funded companies had ceased trading, against 31 per cent of the applicants who were turned down. On those figures, winning a Smart grant did little to keep a company alive. What it changed was how much equity the company went on to raise.

Grant size points the same way. In the same European study, feasibility grants of €50,000 made no measurable difference to a company's chances of raising private equity, while development grants averaging €1.6m more than doubled them. Size matters only because of what it buys. A feasibility grant rarely stretches far enough to produce the proof the next investor needs to see. A development grant can.

The grant that keeps you alive

There is a quieter failure the averages hide. A founder who has not yet convinced prospective investors goes looking for a grant, not to produce the proof those investors are waiting for but to survive while they decide. The grant that is available is rarely the grant the company needs. Its scope belongs to someone else's agenda, a sector programme or a challenge competition, and winning it means reshaping the work to fit. A materials company building a new cathode chemistry ends up applying to fund a grid storage integration project instead, because that is what the competition will pay for. The technology is the same. The milestone is not.

UK founders valued Smart grants precisely because they set no theme: any innovative R&D project, in any sector, could apply. Innovate UK's evaluation found applicants prized the freedom to propose projects aligned with their own priorities rather than themes that did not fit them. With Smart gone, any project that falls outside the current themes has fewer places to go, and the temptation is to reshape it to fit one.

Then the drift begins. Each milestone serves the funder's objectives rather than the company's original thesis, the bet it was founded to prove, and eighteen months later the founder holds a grant report and still no answer to the question the investors asked. It is a pattern seen repeatedly among UK DeepTech companies. The grant does not fail. It postpones the reckoning while the thesis quietly erodes, a variant of the long timeline that becomes an excuse.

Serial grants send the wrong signal

Keep winning grants and investors start to read the company differently. In Howell's US data, the probability of raising venture capital showed a sharp drop the more grants a company had already won from other government agencies, and she concluded that the firms winning award after award may even be dependent on them.

A recent CSIS analysis of the same US programme notes that some investors read repeated awards as a negative signal. Its authors argue that the heaviest winners are not gaming the system but following a different model. They use a succession of grants to fund the development of their technology, then sell the finished product to government, rather than raising venture capital.

For those companies, the model works. A 2024 study of the same programme found that winning multiple awards was not a problem in itself. Selling to government is not what sets them apart: a venture-backed defence startup and a long-established contractor may both sell to the same ministry. What differs is how the development is paid for, and a company financed grant by grant is not the one a venture investor is underwriting.

The same data holds a detail that runs the other way. More than half the firms that raised venture capital within two years of their first grant never applied for the larger follow-on grant, in some cases because outside investors now owned too much of the company to qualify. For them, the grant was a step towards venture money, not a substitute for it.

The UK has reversed the order

For UK founders, the old fallback route of a grant while investors make up their minds is being closed off in Innovate UK's main channel for scaling companies. That channel, Growth Catalyst, now makes the grant conditional on aligned investment from an approved investor partner. For experimental development projects, that investment must be at least twice the size of the grant.

The practical effect is to reverse the sequence many founders relied on. On that programme, the grant can no longer be the thing that keeps a company alive until investors arrive. The investors must arrive first, and the grant then amplifies the round they are already prepared to lead.

The grant now follows investor conviction. It no longer substitutes for it. UK data hints at why investors welcome the pairing: in Antler's study of British Seed rounds, companies with grant funding alongside their Seed reached Series A at 29 per cent, against 17.8 per cent without, though the grant-funded group was small and the comparison is not causal. Innovate UK's March strategic reset goes further, pitching its endorsement as a signal to investors that rigorous technical due diligence has already been done.

The European route is narrower still. UK companies can win the EIC Accelerator's grant only once, and its equity will not reach them until a pending UK-EU agreement takes effect. A founder who spends the grant on the wrong milestone does not get a second attempt.

Choose the grant like a funding round

Before applying for any grant, a founder should put it through three tests. First, what is the most critical proof point the next round will be priced on? Second, does this grant pay for that proof or for a step on the direct path to it? Third, what will winning it cost in scope, matched funding and management time, and will the company that emerges still be the one that an investor wants to back?

A grant that passes all three is the cheapest capital a DeepTech company will ever raise, because it buys the evidence that every later investor will price. A grant that fails them can be the most expensive money of all, however generous its terms. Its real cost is the one thing a startup cannot replace: the time to prove its original thesis.



Let's talk.

back to newsletters

Subscribe to our Newsletter

Stay informed. We will email you when a new newsletter is published.

* indicates required

To subscribe to our Blog Articles click here

search